Dr Nanda on HER2-Low Status Testing in Early-Stage Breast Cancer
Rita Nanda, MD, discusses the importance of testing for HER2-low status in patients with early-stage breast cancer.
Stay updated with breaking news from Rita Nanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rita Nanda, MD, discusses the importance of testing for HER2-low status in patients with early-stage breast cancer.
Rita Nanda, MD, discusses the evolution of treatment with CDK4/6 inhibitors in patients with hormone receptor-positive/HER2-negative breast cancer.
Rita Nanda, MD, discusses the evolution of treatment options for patients with HER2-low breast cancer.
Learn about metastatic breast cancer treatment options, the role of clinical trials in extending survival, and how to find trials that may be right for you.
Rita Nanda, MD, discusses the future of neoadjuvant treatment for patients with HER2-positive breast cancer.